Kopran Ltd share price logo

Kopran Share Price

NSE: KOPRAN

BSE: 524280

Small Cap

Healthcare Sector

₹135.56

+1.97

(+1.47%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Kopran Stock Performance

as on February 17, 2026 at 3:38 pm IST

  • Day's Low

    Day's High

    ₹132.88
    ₹136.18
    downward going graph

    1.98%

    Downside

    0.46%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹119.81
    ₹214.00
    downward going graph

    11.62%

    Downside

    57.86%

    Upside

    downward going graph

Kopran share price movements today

Previous Close
₹133.59
Open
₹133.25
Volume
21.33K
Upper Circuit
₹160.30
Lower Circuit
₹106.88
Day's Low - High
₹132.88 - ₹136.18
52 Week Low - High
₹119.81 - ₹214.00

Kopran Historical Returns

1 Month Return
-6.36 %
3 Month Return
-4.12 %
1 Year Return
-22.38 %
3 Year Return
+ 1.01 %
5 Year Return
+ 12.12 %

Kopran Fundamentals

as on February 17, 2026 at 10:08 am IST

Market Cap

₹645.05 Cr

Return on Equity (ROE)

6.33

PE Ratio (TTM)

39.06

Return on capital employed (ROCE)

8.54

Industry PE ratio

41.05

Beta (LTM)

1.33

P/B Ratio

1.96

Dividend Yield

1.71

PEG Ratio

-6.07

Quarterly Earnings Growth YOY

-10.19

EPS (TTM)

7.98

Sector

Pharmaceuticals

Book Value

107.35

Technical Analysis

Bearish

View Technical Analysis

Kopran Stock Valuation

as on February 17, 2026 at 10:08 am IST

Kopran in the last 5 years

  • Overview

  • Trends

Lowest (3.00x)

March 24, 2020

Today (39.06x)

February 16, 2026

Industry (41.05x)

February 16, 2026

Highest (53.33x)

September 5, 2023

LowHigh

Today’s Price to Earnings Ratio: 39.06x

Kopran Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kopran with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Kopran Ltd image
Kopran Ltd
NA645.052.42%0.6238629
Quest Laboratories Ltd image
Quest Laboratories Ltd
NA200.91-3.36%0.0013103
Gland Pharma Ltd image
Gland Pharma Ltd
BUY29,791.26-4.67%0.536985,616
Makers Laboratories Ltd image
Makers Laboratories Ltd
NA79.92-9.8%0.7110120
Astrazeneca Pharma India Ltd image
Astrazeneca Pharma India Ltd
NA22,260.0028.23%0.001151,716
See all

Kopran Share Price Target

Get share price movements and forecasts by analysts on Kopran.

Source: S&P Global Market Intelligence

Kopran Stock’s Investor Sentiment and Interest

Search interest for Kopran Ltd Stock has decreased by -49% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-49% versus previous 30 day period

Kopran Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
148.88
117
152.59
158.92
186.08
139.44
151.56
166.24
172.36
135.22
117.91
194.28
Other Income
3.78
2.39
0.13
2.43
9.67
2.63
1
0.17
3.26
2.56
0.03
0.07
Total Income
152.66
119.39
152.72
161.35
195.75
142.06
152.56
166.41
175.62
137.77
117.93
194.35
Expenses
136.72
110.69
129.76
135.34
164.39
121.27
136.82
146.4
155.28
121.09
123.19
176.52
Operating Profit
12.16
6.31
22.83
23.58
21.69
18.17
14.74
19.84
17.08
14.13
-5.28
17.76
Operating Profit Margin %
8.17%
5.39%
14.96%
14.84%
11.66%
13.03%
9.73%
11.93%
9.91%
10.45%
-4.48%
9.14%
Profit Before Interest, Tax and Depreciation
15.94
8.7
22.96
26.01
31.36
20.79
15.73
20.01
20.35
16.69
-5.25
17.83
Interest
1.78
1.83
1.94
2.24
2.59
2.18
2.23
2.16
2.77
2.54
2.09
2.67
Depreciation
3.24
3.26
2.77
3.27
3.59
3.87
3.85
4
3.87
4.26
4.28
4.42
Profit Before Tax
10.92
3.61
18.25
20.5
25.18
14.74
9.65
13.85
13.71
9.89
-11.62
10.74
Tax Paid
2.88
0.83
4.48
4.72
6.55
3.64
2.26
3.46
4.03
2.44
-1.7
1.4
Profit After Tax
8.04
2.77
13.77
15.79
18.62
11.1
7.38
10.4
9.68
7.45
-9.92
9.34
Total Net profit including share of profit / Loss from associate company
8.04
2.77
13.77
15.79
18.62
11.1
7.38
10.4
9.68
7.45
-9.92
9.34
EPS
1.67
0.58
2.86
3.28
3.86
2.3
1.53
2.16
2.01
1.54
-2.06
1.93
Actual EPS
1.67
0.58
2.86
3.28
3.86
2.3
1.53
2.16
2.01
1.54
-2.06
1.93
Adjusted EPS
1.67
0.58
2.86
3.28
3.86
2.3
1.53
2.16
2.01
1.54
-2.06
1.93
Diluted EPS
1.67
0.58
2.85
3.28
3.85
2.3
1.53
2.15
2.01
1.54
-2.06
1.93

Kopran Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
318.71
314.71
357.9
359.5
491.81
477.52
550.99
614.59
629.6
Other Income
10.77
9.6
3.06
0.63
17.99
10.6
3.07
14.61
3.98
Total Income
329.48
324.3
360.96
360.13
509.8
488.13
554.05
629.2
633.59
Expenses
282.69
284.31
311.57
313.36
410.03
390.13
499.19
540.18
556.7
Operating Profit
36.02
30.4
46.33
46.14
81.78
87.39
51.8
74.41
72.9
Operating Profit Margin %
11.3%
9.66%
12.94%
12.83%
16.63%
18.3%
9.4%
12.11%
11.58%
Profit Before Interest, Tax and Depreciation
46.79
39.99
49.39
46.77
99.77
98
54.86
89.02
76.88
Interest
13.7
8.6
8.99
8.91
6.24
5.12
6.08
8.59
9.34
Depreciation
8.33
8.51
8.74
9.58
10.19
11.1
12.71
12.89
15.59
Profit Before Tax
24.76
22.88
31.66
28.28
83.34
81.78
36.07
67.54
51.95
Tax Paid
4.85
2.4
7.64
7.27
21.73
20.75
8.83
16.59
13.39
Profit After Tax
19.91
20.49
24.02
21.02
61.61
61.03
27.23
50.96
38.55
Total Net profit including share of profit / Loss from associate company
19.91
20.49
24.02
21.02
61.61
61.03
27.23
50.96
38.55
EPS
4.6
4.74
5.55
4.86
14.24
13.77
5.65
10.57
7.99
Actual EPS
4.6
4.74
5.55
4.86
14.24
13.77
5.65
10.57
7.99
Adjusted EPS
4.6
4.74
5.55
4.86
14.24
13.77
5.65
10.57
7.99
Diluted EPS
4.6
4.74
5.55
4.86
14.24
13.77
5.65
10.55
7.99

Kopran Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
28.63
15.87
25.77
25.41
31
59.95
-33.48
34.02
43.26
41.94
Cash Flow from Investing Activities
-9.07
-17.97
-10.98
-24.86
-12.51
-28.96
-84.13
-12.58
-43.55
-56.42
Cash Flow from Financing Activities
-19.34
1.97
-15.02
-0.59
-18.06
-34.58
122.82
-19.84
0.99
25.88
Net Cash Flow
0.22
-0.12
-0.22
-0.03
0.42
0.1
4.93
1.53
0.69
11.38

Kopran Stock Shareholding Pattern

Numbers in percentages

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
44.3%
44.49%
44.49%
44.49%
44.49%
44.49%
44.49%
44.46%
44.42%
44.42%
44.42%
44.42%
DII
0.14%
0.14%
0.35%
0.14%
1.2%
0.14%
0.22%
0%
0%
0%
0%
0%
FII
0%
0%
0%
0.48%
0.84%
0.68%
1.32%
0.86%
1.12%
0.76%
0.6%
0.36%
Public
55.15%
55.03%
54.77%
54.89%
53.47%
54.7%
53.97%
54.68%
54.45%
54.82%
54.98%
55.22%
Total Outstanding Shares
4,82,10,605
4,82,10,605
4,82,10,605
4,82,10,605
4,82,10,605
4,82,10,605
4,82,10,605
4,82,49,405
4,82,85,605
4,82,85,605
4,82,85,605
4,82,85,605
Total Shareholders
41,567
44,038
53,791
51,636
50,850
51,492
57,154
60,560
58,652
60,194
62,222
60,886

Mutual Funds that own Kopran Stock

Check out the Mutual Funds with significant holdings in Kopran.

Funds
Holdings
Shares Held
Bandhan BSE Healthcare Index Fund Direct Growth
Bandhan BSE Healthcare Index Fund Direct Growth
0.03%
333

Kopran Corporate Actions

View detailed summary of the earnings and dividend history of Kopran.

  • Kopran Ltd Earnings Results

    Kopran Ltd’s net profit fell -10.19% since last year same period to ₹9.34Cr in the Q3 2025-2026. On a quarterly growth basis, Kopran Ltd has generated 194.15% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Kopran Ltd Dividends May,2025

    In the quarter ending March 2025, Kopran Ltd has declared dividend of ₹3.00 per share on 15 May 2025 - translating a dividend yield of 4.47%.

    Read More about Dividends

Indices Featuring Kopran Stock

Check stock indices that include Kopran.

BSE Healthcare

₹43,116.64

0.32 (▲136.68%)

Insights on Kopran Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 117.93 Cr → 194.35 Cr (in ₹), with an average increase of 39.3% per quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 54.98% to 55.22% in Dec 2025 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -9.92 Cr → 9.34 Cr (in ₹), with an average increase of 206.2% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 32.5% return, outperforming this stock by 54.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 170.1% return, outperforming this stock by 169.5%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 44.42% of holdings in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 0.60% to 0.36% in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, KOPRAN stock has moved down by -5.6%

About Kopran Ltd

Kopran, a pharmaceutical company controlled by Parijat Enterprises and promoted by Somani group, came out with a public issue in Nov.92 to finance its backward integration project and expand its antibiotic facility. Its bulk drug plant is approved by the US FDA and UK regulatory authorities, and in 1995 they were awarded Quality Excellence award by Indian Drug Manufacturers Association. Kopran manufactures penicillin and amoxycillin and has collaborations with Germany, South Korea, US and Adac Laboratories.They launched new products for therapeutic groups like asthma, cardiology, diabetes and lifestyle and obtained approval from European Directorate for Quality of Medicines and UK MHRA. Furthermore, they increased their installed capacity of liquids by 3.00 lakhs of liters and tablets/capsules by 270 croresNos during 2001. They also had tied up with EMerck for comarketing a new antiinflammatory drug in India and subsequently launched Cholestat Atorvastatin. Kopran has a high growth rate in exports and has been ranked amongst the top few fastest growing companies in IndiaORG Marg June 2000.

Revenue: ₹194.28Cr as on December 2025 (Q3 FY26)
Net Profit: ₹9.34Cr as on December 2025 (Q3 FY26)
Listing date: 01 Dec, 1994
Chairperson Name: Susheel Somani
OrganisationKopran Ltd
IndustryPharmaceuticals
CEOSusheel Somani
E-voting on sharesClick here to vote

FAQs

What is Kopran share price today?

Kopran share price today stands at ₹135.56 as on . Kopran share today touched a day high of ₹136.18 and a low of ₹132.88.

What is the 52 week high and 52 week low range for Kopran share?

Kopran touched a 52 week high of ₹214 and a 52 week low of ₹119.81. Kopran share price today i.e. is trending at ₹135.56, which is -36.65% down from its 52 week high and 13.15% up from its 52 week low.

What is Kopran's market capitalisation today?

Kopran market capitalisation is ₹645.05 Cr as on .

How to buy Kopran shares?

To buy Kopran shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for KOPRAN or Kopran Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Kopran shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Kopran trading volume today?

Kopran trading volume is 21.33K as on . This means that 21.33K shares of Kopran were bought and sold on the stock market during today's trading session.